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ABSTRACT
Background: It has already been suggested that high abnormal blood lipid 
concentration is associated with hyperglycaemia. However, no data is available about 
the roles of triglycerides (TG) and total cholesterol (TC) levels in diabetes. Here, for 
the first time we investigated the roles of TG and TC levels, gender and abdominal 
fat in the development of newly diagnosed diabetes in China.
Materials and Methods: Two population-based cross-sectional surveys were 
conducted from 2006 to 2009 in Qingdao, China. Newly diagnosed diabetes was 
defined according to FPG and/or 2 h PG criteria. The associations between diabetes 
and TG, and TC levels were assessed by multi-variable logistic regression models.
Results: As compared with non-diabetes, the odds ratio[(95% confidence 
intervals), OR(95% CI)] for diabetes corresponding to hypertriglyceridemia (HTG) 
were 1.54 (1.01, 2.35) in men and 2.02 (1.49, 3.10) in women for TG and accompany 
with Hypercholesterolemia (HTC) 2.93 (1.97, 4.37) and 2.13 (1.49, 3.05) for TC, when 
both were fitted simultaneously in the model adjusting for age, geographic division, 
marital status, school years, family history of diabetes, monthly income, systolic 
blood pressure (SBP), diastolic blood pressure (DBP), waist circumference (WC), 
high density lipoprotein cholesterol (HDL-C), alanine amino transferase (ALT) and 
gamma-glutamyltransferase (GGT).
Conclusions: HTG in both gender, borderline high TC and HTC in men were an 
independent risk factor for diabetes in this Chinese population, however, HTC was 
mediated through abdominal fat for diabetes in women. Our findings may help to 
enhance the current knowledge of diabetes patho-physiology, and the associations 
between TG, TC level and diabetes is also clinically informative.
INTRODUCTION
Diabetes mellitus is a group of metabolic diseases 
characterized by hyperglycemia over a prolonged period 
[1]. It is estimated that a total of415 million people live 
with diabetes in the world [2] and almost 193 million 
people have undiagnosed diabetes worldwide [3].
Prevalence of diabetes is continually increasing in the 
world particularly in China [4, 5], mostly due to obesity, 
overweight, physical inactivity and unhealthy diet.
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Triglycerides (TG) are the main constituents 
of body fat in humans [6], and irresponsible for the 
bidirectional transference of adipose fat and blood 
glucose from the liver. Total cholesterol (TC) is an 
important constituent (30%) of all human cell membranes, 
builds and maintains membranes and modulates membrane 
fluidity over the range of physiological processes. 
Different studies have demonstrated that elevated TG 
and TC is an independent risk factor of cardiovascular 
disorders [7–10]. It is generally known that diabetes 
was often accompanied by several potential risk factors 
of cardiovascular events, such as elevated TG [11, 12] 
and TC [13]. During last few decades, mean TG levels 
have increased in concert with the growing epidemic of 
diabetes mellitus and obesity, however, mean TC levels 
have decreased in America [14, 15].
In 2007, the prevalence rate of diabetes was 9.7% 
in China [5], which was almost two times higher than 
2000–2001 (5.4%) estimates [4]. A large Chinese national 
survey reported in 2010 has suggested that type 2 diabetes 
has become a seriously public health threat in China. 
C-reactive protein (CRP) which is a nonspecific biomarker 
of acute inflammation and is normally produced in the 
liver. There is increasing evidence showing that elevated 
C-reactive protein and gamma glutamyltransferase are the 
potential risk factors for diabetes [16]. However, to the 
best our knowledge, no study has reported an association 
between TG and TC levels with diabetes in the world, 
particularly in China. Therefore, the present study was 
designed to investigate the associations between TG and 
TC concentration and the prevalence of diabetes in a 
Chinese population living in Qingdao, China. 
RESULTS
In this study, a total of 5012 participants were recruited, 
among them 2061 were men (41.1%) and 2951 were women 
(58.9%). The mean age of the 5012 participants was 50.7 
(50.4–51.0) years with a range of 35–74 years. The mean 
values of FPG, 2 h PG, and HbA1c were 5.70 (5.67, 5.73), 
7.34 (7.25, 7.42), and 4.46 (4.43, 4.49), respectively. The 
mean values of TG and TC were 1.40 (1.37, 1.43) and 5.31 
(5.28, 5.34), respectively. The baseline characteristics of the 
participants have been shown in Table 1. 
The prevalence of newly diagnosed diabetes was 
13.0% in men and 11.7% in women. Compared with 
non-diabetes, those individuals with newly diagnosed 
diabetes were older, more obese, and have higher levels 
of systolic blood pressure (SBP), diastolic blood pressure 
(DBP), ALT, TG and TC. Family history of diabetes was 
more common in individuals with diabetes than in those 
without diabetes. However, current smoking and alcohol 
drinking appeared to have no influence on diabetes and 
non-diabetes in either group.
The correlation (R2) for TG and TC in association 
with glucose and HbA1c has been given in Table 2. The 
levels of serum TG and TC has an independent positive 
correlation with FPG, 2 h PG, and HbA1c in the study 
population (Table 2). The OR of HTG in newly diagnosed 
diabetes was significantly higher (P < 0.001) than those 
with normal TG in all models. In this study, there was 
a significantly higher (P < 0.001) association among 
borderline high TG and diabetes in men in model 1 and 
2 and in women in model 1, 2 and 3, but difference was 
not significant (P > 0.005) when both TG and TC were 
included in the same model (Table 2). OR value for 
diabetes was significantly higher (P < 0.001) for HTC 
in men and borderline high TG and HTC in women but 
difference was significantly higher (P < 0.001) when both 
TG and TC were included in the same model. There was 
also a significant interaction of WC with TG (P < 0.001 in 
men and women) and TC (P < 0.001 in men and women) in 
men and women (Table 3), and hence a stratified analysis 
by the WC category was further performed to investigate 
the association between the TG, TC and newly diagnosed 
diabetes. The result revealed that there was significantly 
higher (P < 0.001) association between HTG and diabetes 
in men, but the difference was non-significant (P > 0.005) 
after further adjustment for TG. There was no significant 
(P > 0.005) association between borderline high TG and 
diabetes in men of normal WC. The significant association 
between HTG and diabetes was evaluated in women of 
normal WC, and no significant association (P > 0.005) 
was found after further adjustment models. A significant 
association between HTC and diabetes was observed in 
obese women, however, not in women of normal WC 
(Table 3). Other results were similar to those of men and 
women without WC category.
DISCUSSION
In this population-based cross-sectional study, we 
found that HTG and HTC were positively associated 
with newly diagnosed diabetes in both genders. HTC was 
significantly associated with newly diagnosed diabetes 
only in obese women, while it is a potential independent 
risk factor for diabetes in men of all WC categories. While, 
borderline high TG was also positively associated with 
newly diagnosed diabetes in both genders, but difference 
become non significance after further adjustment for TG. 
Borderline high TC was also positively associated with 
newly diagnosed diabetes in men, but not in women. 
 Previously reported studies had suggested that level 
of TG in serum was positively associated with diabetes. 
Moreover, it has also been shown that increased serum TG 
levels over time enhanced the risk of developing diabetes 
in various populations [17–22], these observation are 
consistent with our results. Many studies have reported 
that abdominal fatis also a primary risk factor for diabetes 
in the world. In the Norwegian cohort study has indicated 
that clinical models such as BMI,men and women aged 
40–45 years; and TG is the important predictors of diabetes 
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[23]. However, our results showed that the individual’s 
with HTG had a higher OR of diabetes as compared with 
those with normal TG in both gender, but there were non-
significant differences for TG between men and women 
with normal WC after further adjustment. The association 
among impaired TG, abdominal obese and diabetes is 
more frequent, whereas the potential patho-physiological 
mechanisms are very complicated and only partially 
understood. Previously reported study has confirmed that 
abdominal obese release excessive free fatty acids, which 
are transported to the liver and pancreas and reduced 
response to insulin signaling (i.e. insulin resistance) [24]. 
The surplus fatty acids are restructured into triglycerides 
in the liver and stored into hepatocytes [25].
Table 1: Baseline characteristics of participants according to glucose
Men women
Non-diabetes diabetes Non-diabetes diabetes
Number (%) 1793 (87.0) 268 (13.0) 2607 (88.3) 344 (11.7)
Age (years) 50.3 (49.8, 50.8) 55.2 (53.9, 56.5)ǂ 49.7 (49.3, 50.1) 56.8 (55.7, 57.9)ǂ
Urban living 587 (32.7) 107 (39.9)* 1436 (55.1) 178 (57.1)
Married, n (%) 1706 (96.4) 248 (93.9) 2448 (95.0) 298 (88.4)ǂ
School years > 9 (%) 673 (37.7) 89 (33.6) 836 (32.2) 60 (17.5)ǂ
Current Smoking (yes, %) 924 (51.7) 144 (54.1) 30 (1.2) 7 (2.1)
Alcohol-drinking (yes, %) 788 (44.1) 134 (50.2) 40 (1.5) 2 (0.6)
Family history of diabetes (yes, %) 245 (14.6) 62 (24.0)ǂ 473 (19.1) 79 (23.7)*
Income (CNY/month), n (%)
  ≤ 599 595 (34.2) 95 (36.4) 1188 (47.4) 174 (52.3)*
 600–1999 847 (48.7) 135 (51.7) 1179 (47.0) 155 (46.5)
  ≥ 2000 292 (17.1) 31 (11.9) 141 (5.6) 4 (1.2)
Body mass index (kg/m2) 25.1 (25.0, 25.3) 26.0 (25.6, 26.4)ǂ 25.4 (25.3, 25.5) 26.7 (26.3, 27.0)ǂ
Waist circumference (cm) 86.2 (85.8, 86.7) 89.0 (87.8, 90.2)ǂ 82.0 (81.7, 82.4) 85.3 (84.3, 86.3)ǂ
Systolic blood pressure (mmHg) 133.3 (132.4, 134.1) 138.7 (136.5, 140.9)ǂ 131.0 (130.2, 131.8) 138.5 (136.3, 140.7)ǂ
Diastolic blood pressure (mmHg) 86.1 (85.6, 86.7) 88.0 (86.5, 89.4)* 83.2 (82.8, 83.6) 85.9(84.7, 87.2)ǂ
Fasting plasma glucose (mmol/L) 5.48 (5.42, 5.53) 7.59 (7.44, 7.74)ǂ 5.46 (5.43, 5.49) 7.26 (7.17, 7.36)ǂ
2 hours post-load plasma glucose (mmol/L) 6.42 (6.30, 6.53) 12.16 (11.86, 12.46)ǂ 6.75 (6.67, 6.83) 12.80 (12.57, 13.03)ǂ
Glycatedhaemoglobin (%) 4.39 (4.34, 4.43) 5.12 (5.00, 5.23)ǂ 4.37 (4.33, 4.40) 5.06 (4.96, 5.17)ǂ
High density lipoprotein cholesterol (mmol/L) 1.63 (1.61, 1.65) 1.63 (1.57, 1.68) 1.67 (1.65, 1.68) 1.59 (1.55, 1.63)ǂ
Alanine amino transferase (U/L) 16.96 (16.22, 17.62) 21.45 (19.63, 23.27)ǂ 14.34 (13.87, 14.81) 16.36 (15.04, 17.69)*
Gamma-glutamyltransferase (U/L) 36.22 (32.88, 38.56) 56.09 (50.00, 62.18)ǂ 18.52 (17.84, 19.20) 26.47 (24.55, 28.38)ǂ
Triglycerides (mmol/L) 1.40 (1.35, 1.46) 1.93 (1.80, 2.07)ǂ 1.30 (1.25, 1.31) 1.88 (1.73, 2.03)ǂ
Normal TG 1365 (76.1) 168 (62.7)ǂ 2070 (79.4) 195 (56.7)ǂ
Borderline high TG 209 (11.7) 47 (17.5) 326 (12.5) 66 (19.2)
Hypertriglyceridemia 219 (12.2) 53 (19.8) 211 (8.1) 83 (24.1)
Total cholesterol (mmol/L) 5.23 (5.18, 5.27) 5.67 (5.55, 5.79)ǂ 5.29 (5.25, 5.32) 5.62 (5.51, 5.72)ǂ
Normal TC 925 (51.6) 85 (31.7)ǂ 1288 (49.4) 106 (30.8)
Borderline high TC 619 (34.5) 102 (38.1) 875 (33.6) 110 (32.0)
Hypercholesterolemia 249 (13.9) 81 (30.2) 444 (17.0) 128 (37.2)
Data are age-adjusted mean (95% confidence interval) or n (%) as indicated. *P < 0.05, ǂ< 0.001, non-diabetes versus diabetes within the same gender
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There is less research available on the association 
of TC and diabetes. In the Australian Diabetes, Obesity 
and Lifestyle Study and the San Antonio Family Heart 
Study [26], TC was strongly associated with diabetes after 
multivariate analysis. Results from the Multiple Risk Factor 
Intervention Trial study indicated that people with elevated 
TC has 2-flod high risk of coronary mortality in the diabetes 
patients as compared with controls [27, 28]. Further, there 
was a relationship between high total cholesterol levels 
and abnormalities in fasting glucose metabolism only 
in Diabetic patients with elevated waist circumference. 
In this study, we also found that the higher TC level was 
positively associated with pre-diabetes and diabetes in 
both gender, especially in women with high abdominal fat. 
This may be explained by the individuals with abdominal 
obese, abnormally in response to 2 h PG, associated with 
high TC level. Those subjects were characterized by high 
waist circumference, a poor glycemic profile and a lipid 
disorder (i.e. high TG level and/or high TC level). One 
possible interpretation of this pattern is that the excessive 
TC may increase dimerization of the enzyme NO synthase, 
which down-regulates the activity of glucokinase, thereby 
reducing the intra-cytoplasmic metabolism of glucose [29].
The strength of our study was the large number 
of subjects, the detailed analysis of the role of TG, TC 
level with diabetes. The application of multiple statistical 
models with different populations and different types of 
variables to evaluate the robustness of the relationship 
between TG, TC level and diabetes are additional strengths 
of this study. Third leading strength was that all newly 
diabetes individuals were diagnosed according to fasting 
plasma glucose and/or 2 h post-load plasma glucose. 
However, there were several limitations in this study. First, 
the current study was a cross-sectional study. Second, 
only TG and TC were performed in the current study, 
and the possible association of lipid disorder with newly 
diagnosed diabetes could not be accurately explored.
MATERIALS AND METHODS
Study population
A population-based cross-sectional diabetes survey 
was conducted in Qingdao in 2006 and 2009, separately. 
Both surveys targeted the population of three urban 
districts (Shinan, Shibei and Sifang) and three rural 
districts (Huangdao, Jiaonan and Jimo). A stratified, 
random cluster sampling method was used to recruit a 
general populationrepresentativeof 12 100 citizens (6100 
in 2006 and 6000 in 2009) aged 35–74 years who have 
lived in Qingdao city for at least 5 years. A total of 10 465 
individuals (5355 in 2006 and 5110 in 2009)were initially 
enrolled in this study with a response rate of 87.8% in 
2006 and 85.2% in 2009, respectively (Figure 1). In this 
study we had used a strict inclusion criteria: 1) newly 
diagnosed diabetes based on fasting plasma glucose (FPG) 
and 2 h post-load plasma glucose (2 h PG); 2) no data 
missing for body mass index (BMI), waist circumference 
(WC), glycatedhaemoglobin (HbA1c), triglycerides, and 
total cholesterol level. A total of 5012 (2061 men and 
2951 women) individuals were included who met the strict 
inclusion criteria for the analysis. Informed consent was 
collected from all participants. This study was approved 
by the local ethics committee at Qingdao Municipal 
Health and Family planning commission.
All eligible individuals were request to visit at the 
local community center, and the object of study was again 
explained individually. All participants were interviewed 
by trained interviewers using a standardized questionnaire 
to elicit information on socio-demographic risk factors. 
Marital status was classified as married/cohabiting or 
single/divorced/widowed). Smoking status was defined as 
current smokers (smoking daily regardless of the amount 
and type of smoking) and non-smokers (including ex-
smoking, smoking now and then, not smoking at all). 
Table 2: Standard β coefficients and R square (R2) for triglycerides and total cholesterol in association 
with fasting plasma glucose, 2 h post-load plasma glucose and glycatedhaemoglobin (%)
Fasting plasma glucose 2 h post-load plasma glucose Glycatedhaemoglobin
Standard 
βcoefficients
R2 P Standard 
βcoefficients




Triglycerides (mmol/L) 0.124 0.101 < 0.001 0.109 0.102 < 0.001 0.119 0.135 < 0.001
Total cholesterol (mmol/L) 0.173 0.114 < 0.001 0.088 0.100 < 0.001 0.047 0.126 < 0.001
Women
Triglycerides (mmol/L) 0.127 0.130 < 0.001 0.134 0.153 < 0.001 0.100 0.198 < 0.001
Total cholesterol (mmol/L) 0.219 0.153 < 0.001 0.113 0.148 < 0.001 0.076 0.195 < 0.001
All
Triglycerides (mmol/L) 0.120 0.105 < 0.001 0.123 0.120 < 0.001 0.114 0.166 < 0.001
Total cholesterol (mmol/L) 0.193 0.123 < 0.001 0.109 0.117 < 0.001 0.068 0.159 < 0.001
Adjusted for age, geographic division, marital status, school years, family history of diabetes, monthly income, waist circumference, systolic blood pressure, 
diastolic blood pressure, high density lipoprotein cholesterol, alanine amino transferase and gamma-glutamyltransferase.
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Table  3:  Odds  ratio  (95%  confidence  interval)  for  newly  diagnosed  diabetes  in  relation  to 
triglycerides and total cholesterol concentration




 Normal TG 750 1.00 1.00 1.00 1.00
 Borderline high TG 69 1.19 (0.47, 2.99) 1.19 (0.47, 3.00) 1.03 (0.40, 2.67) 0.88 (0.33, 2.31)
 Hypertriglyceridemia 50 2.75 (1.26, 6.02) 2.90 (1.31, 6.43) 2.63 (1.09, 6.33) 1.94 (0.77, 4.86)
TC
 Normal TC 462 1.00 1.00 1.00 1.00
 Borderline high TC 280 1.91 (1.07, 3.40) 1.92 (1.08, 3.41) 2.17 (1.18, 3.99) 2.09 (1.14, 3.87)
 Hypercholesterolemia 127 4.45 (2.39, 8.30) 4.48 (2.40, 8.36) 5.23 (2.60, 10.56) 4.88 (2.40, 9.95)
Abdominal obesity
TG
 Normal TG 783 1.00 1.00 1.00 1.00
 Borderline high TG 187 1.64 (1.05, 2.56) 1.62 (1.04, 2.54) 1.54 (0.96, 2.45) 1.41 (0.88, 2.26)
 Hypertriglyceridemia 222 1.90 (1.22, 2.95) 1.82 (1.17, 2.84) 1.58 (0.98, 2.57) 1.38 (0.85, 2.26)
TC
 Normal TC 548 1.00 1.00 1.00 1.00
 Borderline high TC 441 1.61 (1.08, 2.40) 1.61 (1.08, 2.42) 1.57 (1.03, 2.38) 1.50 (0.99, 2.29)
 Hypercholesterolemia 203 2.65 (1.68, 4.16) 2.62 (1.66, 4.13) 2.56 (1.58, 4.16) 2.40 (1.47, 3.91)
All
TG
 Normal TG 1533 1.00 1.00 1.00 1.00
 Borderline high TG 256 1.64 (1.11, 2.44) 1.56 (1.04, 2.32) 1.49 (0.98, 2.25) 1.34 (0.88, 2.04)
 Hypertriglyceridemia 272 2.19 (1.51, 3.20) 2.01 (1.37, 2.96) 1.81 (1.19, 2.74) 1.52 (0.99, 2.33)
TC
 Normal TC 1010 1.00 1.00 1.00 1.00
 Borderline high TC 721 1.69 (1.22, 2.34) 1.66 (1.19, 2.30) 1.65 (1.18, 2.32) 1.59 (1.13, 2.24)




 Normal TG 1026 1.00 1.00 1.00 1.00
 Borderline high TG 93 1.53 (0.67, 3.52) 1.43 (0.61, 3.31) 1.29 (0.54, 3.09) 1.34 (0.55, 3.21)
 Hypertriglyceridemia 55 2.73 (1.19, 6.26) 2.63 (1.14, 6.03) 2.11 (0.87, 5.08) 2.28 (0.93, 5.59)
TC
 Normal TC 650 1.00 1.00 1.00 1.00
 Borderline high TC 362 0.90 (0.49, 1.67) 0.89 (0.48, 1.65) 0.90 (0.47, 1.70) 0.85 (0.44, 1.63)
 Hypercholesterolemia 162 0.87 (0.41, 1.84) 0.87 (0.41, 1.84) 0.80 (0.36, 1.77) 0.70 (0.31, 1.59)
Abdominal obesity
TG
 Normal TG 1239 1.00 1.00 1.00 1.00
 Borderline high TG 299 1.62 (1.13, 2.33) 1.55 (1.08, 2.23) 1.57 (1.08, 2.29) 1.26 (0.85, 1.87)
 Hypertriglyceridemia 239 2.79 (1.94, 4.00) 2.77 (1.92, 3.98) 2.61 (1.78, 3.84) 2.01 (1.34, 3.02)
TC
 Normal TC 744 1.00 1.00 1.00 1.00
 Borderline high TC 623 1.37 (0.95, 1.97) 1.37 (0.95, 1.98) 1.48 (1.01, 2.16) 1.33 (0.91, 1.96)




 Normal TG 2265 1.00 1.00 1.00 1.00
 Borderline high TG 392 1.68 (1.21, 2.34) 1.52 (1.09, 2.12) 1.51 (1.07, 2.13) 1.30 (0.91, 1.85)
 Hypertriglyceridemia 294 3.01 (2.17, 4.19) 2.82 (2.03, 3.93) 2.59 (1.83, 3.68) 2.15 (1.49, 3.10)
TC
 Normal TC 1394 1.00 1.00 1.00 1.00
 Borderline high TC 985 1.23 (0.90, 1.68) 1.21 (0.89, 1.66) 1.29 (0.93, 1.78) 1.17 (0.84, 1.62)
 Hypercholesterolemia 572 2.40 (1.75, 3.30) 2.40 (1.74, 3.30) 2.58 (1.83, 3.64) 2.14 (1.49, 3.06)
Model 1: adjusted for age, geographic division, marital status, school years, family history of diabetes, monthly income, systolic blood pressure, diastolic blood pressure.
Model 2: Model 1+ waist circumference
Model 3: Model 2 + high density lipoprotein cholesterol, alanine amino transferase and gamma-glutamyltransferase.
Model 4: TG and TC fitted simultaneously into the Model 3.
Figure 1: Flow chart of the participants included in the cross sectional analysis.
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Alcohol-drinking status was categorized into current 
drinkers (drinking frequently regardless of the amount and 
type of alcohol) and non-drinkers (including ex-drinkers, 
drinking now and then, not drinking at all). Educational 
attainment was c7ategorized into 2 groups of school years 
≤ 9y and > 9y. Personal monthly income was categorized 
into ≤ 599 Chinese Yuan (CNY), 600–1999 CNY, and 
≥ 2000 CNY. Family history of diabetes was defined as 
having at least one family member (including parents, 
sibling and/or offspring’s) diagnosed as diabetes, without 
regarding the types of diabetes (Table 1). 
Participant’s height and weight were measured 
without shoe and wearing light clothes using digital 
scales and a portable stadiometer, and body mass index 
was calculated as weight in kilograms dividing by height 
in meters squared (kg/m2). Waist circumference was 
measured at the middle of the rib cage and the iliac crest 
to the nearest 0.1 cm. Three consecutive blood pressure 
readings, at least 30sec apart, were taken from the upper 
right arm of the seated participants, and the mean value 
was used in subsequent data analysis. 
Blood samples were collected in locally community 
centers, and transported in a dark box with ice to the 
laboratory and stored at -80 °C freezer. All blood samples 
were analyzed in the central laboratory of Qingdao 
Endocrinology and Diabetes Hospital. Standard 2 h 75g 
oral glucose tolerance tests (OGTT) were administrated in 
all participants without a prior history of diabetes. Plasma 
glucose was measured using glucose oxidase method. 
Glycatedhaemoglobin (HbA1c) was measured using an 
immunoturbidimetry method (Tina-qu.a A1C HIT 917 large; 
Roche Diagnostics). The HbA1c concentration was calculated 
by using the formula provided by Roche Diagnostics: 
[calculated HbA1c (%) = 0.81 × HbA1c (test result) + 2.39] 
to match the values with those found in a conventional 
high performance liquid chromatography (HPLC) method. 
Fasting serum triglycerides (TG), total cholesterol (TC) and 
high-density lipoprotein cholesterol (HLD-C) were measured 
using enzymatic methods. Serum gamma-glutamyltransferase 
(GGT) and alanine aminotransferase (ALT) were determined 
by an International Federation of Clinical Chemistry (IFCC) 
method. 
Classification of individuals
Individuals with previously diagnosed diabetes, 
who reported a history of diabetes and were under 
treatment with either insulin or oral anti-diabetic, were 
excluded from the analysis. Newly diagnosed diabetes 
was determined if FPG ≥ 7.0 mmol/l and/or 2 h PG ≥ 11.1 
mmol/l according to the 2006World Health Organization 
(WHO)/International Diabetes Federation (IDF) standards 
[30]. According to the most recent guideline from Chinese 
Heart Association [31], TG and TC levels were considered 
normal if they were TG < 150 mg/dl and TC < 200 mg/dl, 
borderline high if they were 150–199 mg/dl and 200–240 
mg/dl, high if they were ≥ 200 mg/dl [hypertriglyceridemia 
(HTG)] and ≥ 240 mg/dl [Hypercholesterolemia (HTC)]. 
Central obesity was defined as having waist circumference 
≥ 90 cm for Chinese men and ≥ 80 cm for Chinese women 
[32]. 
Statistical analysis
The Chi-squared test was used to compare the 
difference in prevalence between different glucose 
categories. Age-adjusted mean values and the differences 
of continuous variables were calculated using the general 
linear model in different glucose categories. The linear 
regression analysis was used to investigate the linear 
association of TG and TC with plasma glucose and HbA1c, 
and multivariable logistic regression analysis was used to 
estimate the odds ratio (OR) and 95% confidence intervals 
(95% CI) for the prevalence of diabetes with serum TG 
and TC levels in men and women. All statistical tests were 
two-sided; P values < 0.05 were considered statistically 
significant. Statistical analyses were performed using IBM 
SPSS Statistics 18.0 (SPSS, Chicago, IL). 
CONCLUSIONS 
The elevated TG and TC level have highlighted a 
strong positive association with newly diagnosed diabetes. 
Additionally, borderline high TC in men and HTC in 
addition to being high waist circumference had a highly 
detrimental effect on the presence of diabetes patients in 
this study population. Our findings may help to enhance 
the current knowledge of diabetes patho-physiology, and 
the associations between diabetes and TG and TC level. 
Additionally, a future large-scale, multi-population-based 
studyhas been planned to further investigate the relationship 
between hyperglycemia and the levels of serum TC and TG.
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